Eli Lilly & Co. is tapping the US investment-grade bond market on Monday to help finance its roughly $2.5 billion purchase of ...

The markets have succumbed to the headline pressure around inflation and tariffs, with all three of the major stock market ...

U.S. President Donald Trump and Mexican President Claudia Sheinbaum put their planned tariffs on hold Monday for a month to ...

Jim Cramer, the host of Mad Money, discussed the upcoming market and corporate activity to look forward to this week, which ...

Jim Cramer, the host of Mad Money, discussed the upcoming market and corporate activity to look forward to this week, which ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.

CNBC's Jim Cramer on Friday walked investors through an earnings-heavy week, highlighting reports from Amazon, Alphabet, Eli ...

(Under Azar, Eli Lilly tripled the price of its top-selling insulin drug.) But President Joe Biden's Inflation Reduction Act did follow through. As a result, 10 popular drugs covered under Medicare ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

A satirical X post saying the three major insulin manufacturers in the United States had announced 2,000%-3,000% price ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...